IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q2 2025 Holdings

Filed 2025-08-12 | 6 holdings | $123.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N.V.(PHVS)COMN69605108$77.6M4,410,58162.7%
Maze Therapeutics Inc(MAZE)COM578784100$25.9M2,111,91920.9%
Lyell Immunopharma, Inc.(LYEL)COM55083R203$7.1M800,3995.7%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$5.0M160,0004.0%
Kura Oncology, Inc.(KURA)COM50127T109$4.7M816,8823.8%
Relay Therapeutics Inc.(RLAY)COM75943R102$3.5M1,000,0002.8%